[HTML][HTML] Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves/prior surgical valve repair: a multicenter …

…, A Rago, G Nigro, R Sangiuolo… - … in thrombosis and …, 2018 - thieme-connect.com
This is an observational study to investigate the efficacy and safety of nonvitamin K antagonist
oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic valves or …

A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with …

…, R Iengo, M Canciello, R Sangiuolo… - Circulation …, 2013 - Am Heart Assoc
Background— Current recommendations require a QRS duration of ≥120 ms as a condition
for prescribing cardiac resynchronization therapy (CRT). This study was designed to test …

Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study

…, S Maffei, L Leoni, G Morani, R Sangiuolo… - EP …, 2017 - academic.oup.com
Aims Heart failure (HF) patients with implantable cardioverter-defibrillators (ICD) require
admissions for disease management and out-patient visits for disease management and …

Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and …

R Mango, A Luchetti, R Sangiuolo, V Ferradini… - Circulation …, 2016 - jstage.jst.go.jp
Background: Familial hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited
disorder; mutations in at least 20 genes have been associated. Brugada syndrome (BrS) …

[BOOK][B] Financial instruments: a comprehensive guide to accounting and reporting

R Sangiuolo, LF Seidman - 2008 - books.google.com
… Rosemarie Sangiuolo is an independent consultant with background in the financial services
industry and accounting standard-setting. She specializes in accounting and reporting for …

[HTML][HTML] Exercise Pulmonary Hypertension in Heart Valve Disease

…, A Carbone, S Rega, R Citro, R Sangiuolo… - Reviews in …, 2024 - imrpress.com
The optimal management of heart valve disease (HVD) is still debated and many studies
are underway to identify the best time to refer patients for the most appropriate treatment …

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy

…, M Volpicelli, G Ammirati, R Sangiuolo… - Journal of …, 2022 - Wiley Online Library
Background The effects of lockdown on non‐COVID patients are varied and unexpected. The
aim is to evaluate the burden of cardiac arrhythmias during a lockdown period because of …

Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry

R De Caterina, G Renda, R Sangiuolo… - Giornale Italiano di …, 2014 - europepmc.org
Background Atrial fibrillation (AF) is a common heart rhythm disorder associated with an
increased risk of stroke, heart failure and death. Although available evidence supports the …

Ablating the ventricular insertion of atrio-fascicular Mahaim fiber: what selection criteria should we use?

…, R Vitale, L Ottaviano, EA Sokola, R Sangiuolo… - Journal of interventional …, 2009 - Springer
We reported a patient who underwent RF ablation of the distal insertion of an atrio-fascicular
accessory pathway with decremental properties because of inability to map a suitable …

[HTML][HTML] Mapping and ablation of retrograde conduction during a nearly incessant pacemaker-mediated tachycardia in a patient with third-degree atrioventricular block

…, F Maddaluno, L Casaretti, R Sangiuolo - The Journal of …, 2019 - ncbi.nlm.nih.gov
Patients with third-degree atrioventricular block implanted with a dual-chamber pacemaker
in DDD mode can develop pacemaker-mediated tachycardias if retrograde ventriculoatrial (…